Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald Kohan

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Renal Physiology|December 1, 2012
Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting ductLijun Li, R Mayuri Garikepati, Susanna Tsukerman, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2015
Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney diseaseCheng Wang, Zaiming Luo, Donald Kohan, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and HypertensionDaian Chen, Johannes Stegbauer, Matthew A Sparks, et al.
Nature Cell Biology|January 30, 2023
Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regressionPieter Martino, Raghava Sunkara, Nicholas Heitman, et al.
Journal of the American Society of Nephrology : JASN|September 23, 2021
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR TrialHiddo J L Heerspink, Di Xie, George Bakris, et al.
Diabetes, Obesity & Metabolism|November 13, 2020
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trialJeroen V Koomen, Jasper Stevens, George Bakris, et al.
Journal of the American Society of Nephrology : JASN|April 12, 2014
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyDick de Zeeuw, Blai Coll, Dennis Andress, et al.
Diabetes, Obesity & Metabolism|February 7, 2018
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathyHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.
Diabetes, Obesity & Metabolism|April 1, 2018
Baseline characteristics and enrichment results from the SONAR trialHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Renal Physiology|December 1, 2012
Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting ductLijun Li, R Mayuri Garikepati, Susanna Tsukerman, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2015
Thromboxane prostanoid receptors enhance contractions, endothelin-1, and oxidative stress in microvessels from mice with chronic kidney diseaseCheng Wang, Zaiming Luo, Donald Kohan, et al.
Hypertension (Dallas, Tex. : 1979)|May 4, 2016
Impact of Angiotensin Type 1A Receptors in Principal Cells of the Collecting Duct on Blood Pressure and HypertensionDaian Chen, Johannes Stegbauer, Matthew A Sparks, et al.
Nature Cell Biology|January 30, 2023
Progenitor-derived endothelin controls dermal sheath contraction for hair follicle regressionPieter Martino, Raghava Sunkara, Nicholas Heitman, et al.
Journal of the American Society of Nephrology : JASN|September 23, 2021
Early Response in Albuminuria and Long-Term Kidney Protection during Treatment with an Endothelin Receptor Antagonist: A Prespecified Analysis from the SONAR TrialHiddo J L Heerspink, Di Xie, George Bakris, et al.
Diabetes, Obesity & Metabolism|November 13, 2020
Inter-individual variability in atrasentan exposure partly explains variability in kidney protection and fluid retention responses: A post hoc analysis of the SONAR trialJeroen V Koomen, Jasper Stevens, George Bakris, et al.
Journal of the American Society of Nephrology : JASN|April 12, 2014
The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyDick de Zeeuw, Blai Coll, Dennis Andress, et al.
Diabetes, Obesity & Metabolism|February 7, 2018
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathyHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.
Diabetes, Obesity & Metabolism|April 1, 2018
Baseline characteristics and enrichment results from the SONAR trialHiddo J L Heerspink, Dennis L Andress, George Bakris, et al.
Drugs in R&D|August 24, 2017
Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialDavid J Webb, Blai Coll, Hiddo J L Heerspink, et al.
Pageof 2